Table 3 Salvage RT patient group characteristics
From: Radiotherapy treatment modification for prostate cancer patients based on PSMA-PET/CT
Characteristics | Salvage RT group |
|---|---|
Patients (n) | 17 |
Age (median) | 69 (58–84) |
Radical prostatectomy | 17 |
TNM stage | Â |
pT1-T2 | 11 |
pT3a-b | 5 |
pT4 | 1 |
pN1 | 1 |
pNx | 9 |
Mx | 17 |
Gleason score | Â |
6–7 | 8 |
8–9 | 8 |
Positive surgical margins after radical prostatectomy | 5 |
Pre-PSMA-PET/CT PSA (ng/ml) (median) | 2.8 (0.1–21.8) |
Postoperative PSA (ng/ml) (median) | 0.7 (0–7) |
PSA (ng/ml) at PSMA-PET/CT in PET positive pts | 1.6 (0.4–13.8) |
PSA (ng/ml) at PSMA-PET/CT in PET negative pts | 0.6 (0.1–1) |
PSMA-PET/CT revealed metastases in | Â |
FR only | 6 |
Lymph nodes | 7 |
Bones | 1 |
FR and lymph nodes | 1 |